OrthoTreat, Ltd.
OrthoTreat is dedicated to advancing bone regeneration through innovative solutions that enhance the body's physiological healing mechanisms. Their unique approach, OsteoRegulation, focuses on optimizing biological processes rather than merely providing materials for bone formation, aiming for faster, better, and stronger healing outcomes.
Industries
Nr. of Employees
small (1-50)
OrthoTreat, Ltd.
WeWork Hazerem, 7 Hapelech st. Tel Aviv Jaffa, Israel
Products
ModulX (dual‑drug bone regeneration therapy)
A dual‑active therapeutic formulation combining a statin‑class small molecule and a CB2 receptor agonist delivered via a controlled‑release system to modulate inflammation, stimulate osteogenesis and support bone healing across inflammatory, reparative and remodeling phases.
ModulX (dual‑drug bone regeneration therapy)
A dual‑active therapeutic formulation combining a statin‑class small molecule and a CB2 receptor agonist delivered via a controlled‑release system to modulate inflammation, stimulate osteogenesis and support bone healing across inflammatory, reparative and remodeling phases.
Services
Publicly accessible repository of articles, reviews and videos on bone regeneration and related scientific topics.
Restricted online community for experts and members to share findings, access lab updates and participate in surveys and discussions.
Publicly accessible repository of articles, reviews and videos on bone regeneration and related scientific topics.
Restricted online community for experts and members to share findings, access lab updates and participate in surveys and discussions.
Expertise Areas
- Bone regeneration
- Fracture healing
- Osseointegration
- Osteoporosis therapeutics
Key Technologies
- Dual‑drug combination therapy
- Controlled‑release drug delivery systems
- Statin‑based osteogenic modulation
- CB2 receptor agonist modulation